Business
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
Hi, what are you looking for?
Jewish Business News
Business
– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. – The US Supreme...
Business
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
Business
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
Business
Israel’s Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commercializing innovative expandable devices for spine surgery, has signed...
Business
– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE:...
Business
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about...
Business
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Business
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
Business
Neri Oxman of MIT has joined forces with 3D printing company Stratasys to develop four varieties of “wearable skins” that would potentially enable human...